Potential Cost Savings Attributable to Influenza Vaccination of School-aged Children
Open Access
- 1 June 1999
- journal article
- Published by American Academy of Pediatrics (AAP)
- Vol. 103 (6) , e73
- https://doi.org/10.1542/peds.103.6.e73
Abstract
Objective.: To analyze the costs and benefits of influenza vaccination of healthy school-aged children. Design.: The analysis was based on data from the literature. Total costs included direct medical costs for vaccination, physician visits, and treatment as well as indirect costs. Indirect costs were in the form of lost productivity when working parents stayed home to care for ill children or to take children to an office for vaccination. The total costs of vaccination strategies were compared with the total cost of not vaccinating. For the base case, the vaccine was assumed to have no effect on rates of otitis media. Setting.: Two hypothetical scenarios were investigated 1) individual-initiated vaccination and 2) vaccination in a group-based setting. The former scenario required the child to be accompanied to a clinic by a parent during usual work hours. Results.: Vaccination resulted in a net savings per child vaccinated of $4 for individual-initiated vaccination and of $35 for group-based vaccination. The savings were caused primarily by averted indirect costs. Moderate increases in the cost of vaccination or reductions in the rate of influenza would eliminate the savings for individual-initiated vaccination but not for group-based vaccination. Alternatively, if influenza vaccination was effective in reducing rates of otitis media, the net savings from vaccination would be substantially higher than the base case. Conclusion.: Vaccination of school-aged children against influenza could have substantial financial benefits to society, especially if performed in a group-based setting. influenza, cost-effectiveness, vaccination, children, cost.Keywords
This publication has 21 references indexed in Scilit:
- The Guillain–Barré Syndrome and the 1992–1993 and 1993–1994 Influenza VaccinesNew England Journal of Medicine, 1998
- Influenza Immunization for ChildrenNew England Journal of Medicine, 1998
- The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in ChildrenNew England Journal of Medicine, 1998
- Comparison of US Inactivated Split-Virus and Russian Live Attenuated, Cold-Adapted Trivalent Influenza Vaccines in Russian SchoolchildrenThe Journal of Infectious Diseases, 1996
- The Effectiveness of Vaccination against Influenza in Healthy, Working AdultsNew England Journal of Medicine, 1995
- A Randomized Controlled Trial of Cold-Adapted and Inactivated Vaccines for the Prevention of Influenza A DiseaseThe Journal of Infectious Diseases, 1994
- Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia: I. Safety and efficacy in two Moscow schools, 1987/88Vaccine, 1993
- The Impact of Influenza Vaccination on Respiratory Illness at a Boarding SchoolJournal of American College Health, 1992
- Emergence and Apparent Transmission of Rimantadine-Resistant Influenza A Virus in FamiliesNew England Journal of Medicine, 1989
- Longitudinal Studies of Types A and B Influenza among Seattle Schoolchildren and Families, 1968-1974The Journal of Infectious Diseases, 1976